What Counts as a Medical Device
A medical device is broadly defined as any instrument, apparatus, implant, software, material, or other article intended by the manufacturer to be used for medical purposes, like:
Diagnosis, prevention, monitoring, treatment or alleviation of disease
Modifying anatomy or a physiological process
In vitro diagnostics (e.g., reagents or instruments for testing body samples)
In different jurisdictions, there is a “qualification” or “borderline” assessment to decide whether a product is actually regulated as a medical device. For example, in the UK, they look at: the intended use, mode of action, labelling, and how similar products are regulated.
Why We Grade (Classify) Devices
To assess risk: Devices that pose more risk to patients/users need more stringent regulation.
To determine regulatory pathway: What kind of pre-market approval is needed, what documentation, what tests.
To establish post-market requirements: More risky devices may require more post-market surveillance, reporting, etc.
Common Classification Systems
Here are some of the major classification systems and how grading works in different regions:
USA (FDA)
The FDA divides medical devices into three classes: Class I, Class II, Class III.
Risk basis: The classification depends on how risky the device is to patients or users.
Regulatory controls:
General Controls: Required for all classes (e.g., establishment registration, labeling, quality systems).
Special Controls: Additional controls for Class II (e.g., performance standards, special labeling).
Premarket Approval (PMA): Required for Class III devices (typically high risk) unless exempted.
Reclassification: The FDA can reclassify devices as new safety data emerges.
European Union / UK (MDR)
Under EU MDR (Medical Device Regulation 2017/745) and UK regulations, devices are classified more granularly: Class I, Class IIa, Class IIb, and Class III.
The classification depends on factors like:
Intended use
Duration of contact with the body
Whether the device is invasive or implantable
Whether it’s active (e.g., powered)
Whether it contains medicinal substances
Conformity assessment: The higher the class, the more rigorous the conformity assessment (involvement of a Notified Body / Approved Body).
Classification rules: Annex VIII of MDR defines “rules” (e.g., how to classify based on invasiveness, duration, etc.).
Other Regions (e.g. Australia – TGA)
The Therapeutic Goods Administration (TGA) in Australia also uses a risk-based classification system.
Manufacturers must classify their devices correctly because the required regulatory evidence depends on class.
The intended purpose is critical: the same physical device can be in different classes depending on how it’s used.
Examples of Device Classes
Here are some example devices by class (depending on region):
Low risk (Class I): Non-electrical bandages, examination gloves, simple surgical instruments.
Medium risk (Class II / IIa / IIb): Infusion pumps, ventilators, diagnostic imaging devices, some software used for diagnosis.
High risk (Class III): Pacemakers, implantable defibrillators, joint replacements, devices that sustain or support life.
Key Implications of Classification
Regulatory Burden
Higher-class devices usually require more documentation, more clinical data, and more rigorous quality systems.
For instance, Class III devices under FDA often need a PMA, needing detailed safety & effectiveness data.
Cost and Time to Market
Higher classes = more testing and validation = higher cost and longer regulatory timelines.
But the potential payoff (for high-risk / high-value devices) can justify the investment.
Post-Market Obligations
More rigorous vigilance, reporting, and possibly post-market clinical follow-up for high-risk devices.
Quality management systems (e.g., ISO 13485) are often required, especially for higher-risk devices.
Design & Risk Management
Risk management (e.g., according to ISO 14971) is closely tied to classification: you need to demonstrate that you’ve identified and mitigated risks appropriately.
The classification also influences how you design your device, what materials you use, how you validate it, etc.
Challenges & Nuances
Borderline Products: Some products are hard to classify (e.g., “is this a medical device or a consumer product?”). Regulators (like the MHRA in the UK) provide guidance.
Software as a Medical Device (SaMD): Software (even standalone) can be classified depending on what it does (diagnosis, clinical decision support, etc.).
Reclassification: As technology evolves or new risk data emerges, devices may be reclassified.
Global Market Differences: Classification rules differ by region, so a device class in the US may not directly correspond to the same class in Europe or Australia.
Why “Grading” Matters for Biotech / Medical-Adjacent Innovations
If you’re working in biotech (or adjacent fields), understanding device classification is critical because:
If you build a biotech product that is also a device (e.g., a biosensor, diagnostic kit, implantable bioprobe), you’ll need to navigate device regulation.
Risk drives design decisions: Knowing what class your device is likely to be can influence how you design it (materials, redundancy, safety).
Regulatory strategy: Device class will affect your go-to-market plan, regulatory budget, clinical trials, quality systems, and post-market strategy.


Leave a Reply